H&R GMBH & CO KGAA (2HRA.DE) Stock Fundamental Analysis
FRA:2HRA - Deutsche Boerse Ag - DE000A2E4T77 - Common Stock - Currency: EUR
We assign a fundamental rating of 4 out of 10 to 2HRA. 2HRA was compared to 66 industry peers in the Chemicals industry. Both the profitability and the financial health of 2HRA get a neutral evaluation. Nothing too spectacular is happening here. 2HRA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
2HRA had positive earnings in the past year.
2HRA had a positive operating cash flow in the past year.
Of the past 5 years 2HRA 4 years were profitable.
2HRA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.05%, 2HRA is in line with its industry, outperforming 51.52% of the companies in the same industry.
2HRA has a Return On Equity (2.49%) which is comparable to the rest of the industry.
The Return On Invested Capital of 2HRA (2.65%) is comparable to the rest of the industry.
2HRA had an Average Return On Invested Capital over the past 3 years of 4.21%. This is below the industry average of 6.51%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.05% | ||
| ROE | 2.49% | ||
| ROIC | 2.65% |
ROA(3y)2.22%
ROA(5y)2.24%
ROE(3y)5.04%
ROE(5y)5.21%
ROIC(3y)4.21%
ROIC(5y)4.11%
1.3 Margins
Looking at the Profit Margin, with a value of 0.79%, 2HRA is in line with its industry, outperforming 46.97% of the companies in the same industry.
In the last couple of years the Profit Margin of 2HRA has declined.
The Operating Margin of 2HRA (2.41%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of 2HRA has grown nicely.
2HRA has a worse Gross Margin (23.61%) than 65.15% of its industry peers.
In the last couple of years the Gross Margin of 2HRA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.41% | ||
| PM (TTM) | 0.79% | ||
| GM | 23.61% |
OM growth 3Y-26.17%
OM growth 5Y25.85%
PM growth 3Y-42.71%
PM growth 5YN/A
GM growth 3Y-4.08%
GM growth 5Y2.14%
2. Health
2.1 Basic Checks
2HRA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
2HRA has about the same amout of shares outstanding than it did 1 year ago.
2HRA has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for 2HRA has been reduced compared to a year ago.
2.2 Solvency
2HRA has an Altman-Z score of 2.19. This is not the best score and indicates that 2HRA is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.19, 2HRA perfoms like the industry average, outperforming 53.03% of the companies in the same industry.
The Debt to FCF ratio of 2HRA is 9.97, which is on the high side as it means it would take 2HRA, 9.97 years of fcf income to pay off all of its debts.
2HRA has a better Debt to FCF ratio (9.97) than 60.61% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that 2HRA is not too dependend on debt financing.
2HRA's Debt to Equity ratio of 0.15 is amongst the best of the industry. 2HRA outperforms 80.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 9.97 | ||
| Altman-Z | 2.19 |
ROIC/WACC0.47
WACC5.59%
2.3 Liquidity
A Current Ratio of 1.53 indicates that 2HRA should not have too much problems paying its short term obligations.
With a Current ratio value of 1.53, 2HRA perfoms like the industry average, outperforming 40.91% of the companies in the same industry.
2HRA has a Quick Ratio of 1.53. This is a bad value and indicates that 2HRA is not financially healthy enough and could expect problems in meeting its short term obligations.
2HRA has a Quick ratio of 0.80. This is in the lower half of the industry: 2HRA underperforms 78.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.8 |
3. Growth
3.1 Past
2HRA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.56%.
The earnings per share for 2HRA have been decreasing by -40.40% on average. This is quite bad
The Revenue has decreased by -1.04% in the past year.
2HRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.47% yearly.
EPS 1Y (TTM)1.56%
EPS 3Y-40.4%
EPS 5YN/A
EPS Q2Q%636.62%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y4.04%
Revenue growth 5Y4.47%
Sales Q2Q%2.91%
3.2 Future
Based on estimates for the next years, 2HRA will show a very strong growth in Earnings Per Share. The EPS will grow by 27.75% on average per year.
The Revenue is expected to grow by 1.32% on average over the next years.
EPS Next Y34.75%
EPS Next 2Y40.41%
EPS Next 3Y27.75%
EPS Next 5YN/A
Revenue Next Year-0.8%
Revenue Next 2Y0.87%
Revenue Next 3Y1.32%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
2HRA is valuated rather expensively with a Price/Earnings ratio of 17.82.
2HRA's Price/Earnings ratio is a bit cheaper when compared to the industry. 2HRA is cheaper than 68.18% of the companies in the same industry.
When comparing the Price/Earnings ratio of 2HRA to the average of the S&P500 Index (26.25), we can say 2HRA is valued slightly cheaper.
2HRA is valuated correctly with a Price/Forward Earnings ratio of 15.45.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 2HRA indicates a somewhat cheap valuation: 2HRA is cheaper than 62.12% of the companies listed in the same industry.
2HRA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.15, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.82 | ||
| Fwd PE | 15.45 |
4.2 Price Multiples
2HRA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. 2HRA is cheaper than 100.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 2HRA indicates a somewhat cheap valuation: 2HRA is cheaper than 77.27% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.19 | ||
| EV/EBITDA | 2.6 |
4.3 Compensation for Growth
2HRA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as 2HRA's earnings are expected to grow with 27.75% in the coming years.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y40.41%
EPS Next 3Y27.75%
5. Dividend
5.1 Amount
2HRA has a Yearly Dividend Yield of 2.01%.
2HRA's Dividend Yield is comparable with the industry average which is at 3.12.
Compared to an average S&P500 Dividend Yield of 2.40, 2HRA has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.01% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
35.04% of the earnings are spent on dividend by 2HRA. This is a low number and sustainable payout ratio.
DP35.04%
EPS Next 2Y40.41%
EPS Next 3Y27.75%
FRA:2HRA (5/30/2025, 7:00:00 PM)
4.99
+0.01 (+0.2%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners1.39%
Inst Owner ChangeN/A
Ins Owners6.06%
Ins Owner ChangeN/A
Market Cap185.73M
Analysts40
Price Target4.01 (-19.64%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.01% |
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP35.04%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-37.57%
PT rev (3m)-37.57%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-13.24%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.88%
Revenue NY rev (3m)-2.52%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.82 | ||
| Fwd PE | 15.45 | ||
| P/S | 0.14 | ||
| P/FCF | 12.19 | ||
| P/OCF | 2.64 | ||
| P/B | 0.44 | ||
| P/tB | 0.47 | ||
| EV/EBITDA | 2.6 |
EPS(TTM)0.28
EY5.61%
EPS(NY)0.32
Fwd EY6.47%
FCF(TTM)0.41
FCFY8.2%
OCF(TTM)1.89
OCFY37.82%
SpS35.95
BVpS11.47
TBVpS10.66
PEG (NY)0.51
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.05% | ||
| ROE | 2.49% | ||
| ROCE | 4.47% | ||
| ROIC | 2.65% | ||
| ROICexc | 2.96% | ||
| ROICexgc | 3.11% | ||
| OM | 2.41% | ||
| PM (TTM) | 0.79% | ||
| GM | 23.61% | ||
| FCFM | 1.14% |
ROA(3y)2.22%
ROA(5y)2.24%
ROE(3y)5.04%
ROE(5y)5.21%
ROIC(3y)4.21%
ROIC(5y)4.11%
ROICexc(3y)4.64%
ROICexc(5y)4.53%
ROICexgc(3y)4.9%
ROICexgc(5y)4.79%
ROCE(3y)7.11%
ROCE(5y)6.95%
ROICexcg growth 3Y-25.59%
ROICexcg growth 5Y22.95%
ROICexc growth 3Y-25.37%
ROICexc growth 5Y23.82%
OM growth 3Y-26.17%
OM growth 5Y25.85%
PM growth 3Y-42.71%
PM growth 5YN/A
GM growth 3Y-4.08%
GM growth 5Y2.14%
F-Score5
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 9.97 | ||
| Debt/EBITDA | 0.67 | ||
| Cap/Depr | 87.57% | ||
| Cap/Sales | 4.11% | ||
| Interest Coverage | 3.5 | ||
| Cash Conversion | 73.93% | ||
| Profit Quality | 143.37% | ||
| Current Ratio | 1.53 | ||
| Quick Ratio | 0.8 | ||
| Altman-Z | 2.19 |
F-Score5
WACC5.59%
ROIC/WACC0.47
Cap/Depr(3y)102.18%
Cap/Depr(5y)93.34%
Cap/Sales(3y)4.27%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1.56%
EPS 3Y-40.4%
EPS 5YN/A
EPS Q2Q%636.62%
EPS Next Y34.75%
EPS Next 2Y40.41%
EPS Next 3Y27.75%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y4.04%
Revenue growth 5Y4.47%
Sales Q2Q%2.91%
Revenue Next Year-0.8%
Revenue Next 2Y0.87%
Revenue Next 3Y1.32%
Revenue Next 5YN/A
EBIT growth 1Y4.91%
EBIT growth 3Y-23.19%
EBIT growth 5Y31.47%
EBIT Next Year199.94%
EBIT Next 3Y49.9%
EBIT Next 5YN/A
FCF growth 1Y-75.2%
FCF growth 3YN/A
FCF growth 5Y-5.95%
OCF growth 1Y-41.01%
OCF growth 3Y23.36%
OCF growth 5Y-6.03%